(Press-News.org) PHILADELPHIA — Obese women might be able to eliminate their increased risk for postmenopausal breast cancer by taking measures during perimenopause to prevent weight gain and to therapeutically control the metabolic effects of their obesity, according to the results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.
"Obese postmenopausal women have increased risk for breast cancer and poorer clinical outcomes compared with postmenopausal women who are lean," said Paul S. MacLean, Ph.D., associate professor of medicine at the University of Colorado Anschutz Health and Wellness Center in Aurora, Colo. "The reasons for this are not fully understood.
"Unfortunately you cannot do the studies needed to address this issue in humans. So, we merged rat models of obesity, breast cancer and menopause to best mimic the events that link premenopausal obesity to an increased rate of postmenopausal breast cancer."
During menopause, women often gain weight because they consume more food than their body needs. In a previous study, MacLean and colleagues used their rat model to show that weight gain following surgical ovariectomy, which models menopause, helped promote breast tumor development in obese rats.
In this study, they confirmed that obesity and overfeeding after surgical ovariectomy together drove aggressive tumor growth and progression.
One reason was that obese rats were unable to appropriately handle the excess sources of energy, in the form of glucose and dietary fat, which accumulated as a result of overfeeding after surgical ovariectomy. Lean rats stored the excess glucose and dietary fat from overfeeding in liver, fat, muscle and healthy breast tissue, a normal metabolic response to overfeeding. In contrast, the healthy tissues in obese rats failed to increase uptake of glucose and dietary fat, but the breast tumors dramatically increased uptake of glucose.
A second reason for the enhanced tumor growth and progression in obese rats compared with lean rats was that tumors from the two groups of animals had different molecular profiles. Tumors from obese rats had higher levels of expression of the progesterone receptor (PR), which was related to higher expression of genes involved in energy use and proliferation.
A similar pattern of increased expression of genes involved in energy use and cell growth was seen in human PR-positive breast tumors from postmenopausal women. According to MacLean, a final piece of evidence indicating that obesity and overfeeding during the menopausal transition converge to promote tumor growth and progression was that the antidiabetic drug metformin reduced tumor burden in obese rats after surgical ovariectomy.
"If our findings in rats translate to humans, it means that the perimenopausal period is a critical window of time for determining breast cancer risk later in life," said MacLean. "This, in turn, means that an obese woman's risk for postmenopausal breast cancer and poor clinical outcome could be reduced by perimenopausal lifestyle modifications, such as restricting food consumption and increasing exercise, and/or perimenopausal use of drugs, such as metformin, to improve metabolic control."
MacLean and colleagues are now testing this hypothesis in the rat model.
###
Follow the AACR on Twitter: @aacr #aacr
Follow the AACR on Facebook: http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's first and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 17,000 attendees. In addition, the AACR publishes seven peer-reviewed scientific journals and a magazine for cancer survivors, patients and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org.
Obesity and overeating during menopause together promote breast tumor growth and progression
2012-12-07
ELSE PRESS RELEASES FROM THIS DATE:
Existing drugs may help more breast cancer patients
2012-12-07
More patients can benefit from highly effective breast cancer drugs that are already available, according to DNA sequencing studies by researchers at Washington University School of Medicine in St. Louis and other institutions.
The investigators found that some women with the HER2 negative subtype may benefit from anti-HER2 drugs even though standard tests don't indicate they are candidates for the drugs.
"These patients are going to be missed by our routine testing for HER2 positive breast cancer," says Ron Bose, MD, PhD, assistant professor of medicine. "Currently ...
Protein tied to cancer-drug resistance in mice
2012-12-07
SAN ANTONIO, TX (December 7, 2012)—Blocking a specific protein renders tumors more vulnerable to treatment in mice, suggesting new therapies could eventually achieve the same in humans, according to new research from Fox Chase Cancer Center to be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium on Friday, December 7, 2012.
"Hopefully, with further testing, this research could one day result in a new therapy that blocks the effect of this protein and, in turn, boosts the effects of cancer drugs," says study author Elizabeth Hopper-Borge, PhD, Assistant ...
Study compares standard against newer treatment in women whose breast cancer has spread
2012-12-07
(Lebanon, NH, 12/7/12) — Results from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate with capecitabine, a standard drug used for chemotherapy today in women with previously treated metastatic breast cancer, showed that eribulin demonstrated a trend toward improved overall survival. This study was presented today by Peter A. Kaufman, M.D., during the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.
"We didn't show a statistically significant superiority of eribulin over capecitabine, which was our goal," said Peter A. Kaufman, ...
The effect of treating institution on outcomes in head and neck cancer
2012-12-07
Alexandria, VA — Patients with head and neck cancer receiving radiation treatment at an academic center have a higher survival rate than those receiving treatment at a community center, according to a study in the December 2012 issue of Otolaryngology–Head and Neck Surgery.
"Despite similar rates of treatment completion and rate of treatment breaks between groups, patients treated in academic centers had more advanced cancer but better survival," the authors state in their conclusion.
The study evaluated differences in patient characteristics, treatment, and cancer ...
Point of light
2012-12-07
PASADENA, Calif.—As technology advances, it tends to shrink. From cell phones to laptops—powered by increasingly faster and tinier processors—everything is getting thinner and sleeker. And now light beams are getting smaller, too.
Engineers at the California Institute of Technology (Caltech) have created a device that can focus light into a point just a few nanometers (billionths of a meter) across—an achievement they say may lead to next-generation applications in computing, communications, and imaging.
Because light can carry greater amounts of data more efficiently ...
How the common 'cat parasite' gets into the brain
2012-12-07
"We believe that this knowledge may be important for the further understanding of complex interactions in some major public health issues, that modern science still hasn't been able to explain fully", says Antonio Barragan, researcher at the Center for Infectious Medicine at Karolinska Institutet and the Swedish Institute for Communicable Disease Control. "At the same time, it's important to emphasize that humans have lived with this parasite for many millennia, so today's carriers of Toxoplasma need not be particularly worried".
The current study, which is published ...
Putting electronic cigarettes to the test
2012-12-07
Electronic cigarettes are experiencing somewhat of a boom at the moment. An estimated two million people in Germany have already turned to the vapor cigarette, which many view as a healthy alternative to conventional smoking. However, a number of voices, primarily from the political sphere, are warning of possible health risks, claiming that the long-term consequences cannot yet be foreseen. Studies to date have come to mixed conclusions. There is a general lack of substantiated facts, fuelling an ongoing battle between supporters and opponents. By carrying out a new, independent ...
Group interaction among elderly is the key to significant health outcomes
2012-12-07
The health benefits of 'water clubs' in care homes for the elderly, where residents gather together regularly to drink water , owe as least as much to the social nature of the activity as to the value of drinking water itself, an investigation by psychologists has shown.
The study, funded by the Economic and Social Research Council (ESRC), supports other findings that interventions aimed at improving individuals' wellbeing and quality of life can be far more effective if they are carried out among groups of people in ways that generate a strong sense of group identity.
A ...
X-ray vision can reveal the moment of birth of violent supernovae
2012-12-07
A team of astronomers led by the University of Leicester has uncovered new evidence that suggests that X-ray detectors in space could be the first to witness new supernovae that signal the death of massive stars.
Astronomers have measured an excess of X-ray radiation in the first few minutes of collapsing massive stars, which may be the signature of the supernova shock wave first escaping from the star.
The findings have come as a surprise to Dr Rhaana Starling, of the University of Leicester Department of Physics and Astronomy whose research is published in the ...
Winning the battle against leukaemia: Positive early results in clinical trial for DNA vaccine
2012-12-07
Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.
Furthermore, T cell immune responses, including those of the "killer T cells," were detected. Antibody and T cell responses are strong signals of the DNA vaccine's potential to treat the disease.
Presented at the DNA Vaccines 2012 conference in California by Christian Ottensmeier, the trial's principal investigator and Professor of Experimental Cancer Research at the University of Southampton, these interim ...